Departure of Directors or Certain


 


On August 1, 2022, the
Compensation Committee of the Company awarded restricted shares of the Company’s common stock to the named executive officers pursuant
to the Company’s 2020 Equity Incentive Plan. The shares will vest equally on each of the first three anniversaries of the date of
the grant. The grant of restricted stock to each named executive officer is listed below.


 




Name of Executive

 


Shares of Restricted Stock Granted

 



David S. Chernow

 


 

250,000

 



Robert A. Ortenzio

 


 

250,000

 



Rocco A. Ortenzio

 


 

150,000

 



Martin F. Jackson

 


 

150,000

 



Michael E. Tarvin

 


 

100,000

 



 







 


SIGNATURE


 


Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.


 




 


SELECT MEDICAL HOLDINGS CORPORATION



 


 


 



Date: August 4, 2022


By:


/s/ Michael E. Tarvin



 


 


Michael E. Tarvin

Executive Vice President, General Counsel and Secretary



 





 



 







makes a similar move, sign up!

Auto Refresh

Feedback